[APLS] YoY Quarter Result on 31-Dec-2019 [#Q4]

Stock
[APLS] Apellis Pharmaceuticals, Inc.
Announcement Date
27-Feb-2020
Financial Year
2019
Quarter
31-Dec-2019 [#Q4]
Profit Trend
QoQ- -62.14%
YoY- -210.53%
Quarter Report
APLS's Result
APLS's Financial Summary
View:
Show?
Quarter Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 22,663 60,290 250,000 -142 12 12 0 -
PBT -167,462 -147,581 80,110 -113,217 -36,459 -18,256 -6,620 71.29%
Tax -1,471 352 2 3,981 2,383 -17,896 -6,679 -22.27%
NP -165,991 -147,933 78,265 -113,217 -36,459 -18,256 -6,620 71.04%
Tax Rate - - -0.00% - - - - -
Total Cost 188,654 208,223 171,735 113,075 36,471 18,267 6,620 74.72%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin -732.43 -245.37 31.31 79,646.45 -315,885.24 -158,169.26 0.00 -
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS -1.50 -1.73 0.99 -1.54 -0.65 -0.36 -0.37 26.26%
EPS Diluted -1.50 -1.73 0.99 -1.54 -0.63 -0.36 -0.37 26.26%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.